Skip to main content
. 2011 Aug 4;25(10):1710–1724. doi: 10.1210/me.2011-1042

Fig. 9.

Fig. 9.

MAPK-dependent control of PRA/PRB expression ratio. Control of PRA and PRB stabilities and PRA/PRB ratio by p38 and p42/44 MAPK activities is schematically summarized. Progesterone (Prog) and specific MAPK inhibitors are indicated (U0, U0126; PD, PD169316).